AUTH/3288/12/19: NHS Worker v Biogen — alleged promotion by an MSL at a social event (No breach)

📅 2019 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/3288/12/19
ComplainantAnonymous, non-contactable individual who stated that he/she worked in the NHS
CompanyBiogen
ProductTysabri
AllegationMSL promoted Tysabri and its benefits to an MS patient at a social event, leading to a request to switch therapy
SettingWedding/social event (May 2019; described as summer 2019)
Complaint received13 December 2019
Case completed16 September 2020
Applicable Code year2019
AppealNo appeal
DecisionNo breach
Clauses considered2; 9.1; 12.1; 15.2; 26.1; 26.2

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • An anonymous, non-contactable individual who said they worked in the NHS complained about a conversation at a social event (a wedding) between a Biogen Idec medical science liaison (MSL) and another guest who was an MS patient.
  • The complainant alleged the MSL discussed Tysabri and its benefits, and that the patient later asked their MS nurse to switch them from a competitor therapy to Tysabri (which was agreed, against the nurse’s advice).
  • The complainant alleged this amounted to inappropriate promotion/advice to a patient/public.
  • Biogen stated the MSL disclosed they worked in pharma and for Biogen only when asked, did not mention Tysabri or any Biogen/competitor product, advised the guest to seek advice from their health professional, and deliberately ended the topic.
  • The Panel noted the complainant provided no specific detail of what was said and could not be contacted; it was unclear whether the complainant was present for the conversation.
  • The Panel considered it possible the guest later searched online for information about Biogen and Tysabri after learning the MSL worked for Biogen.
⚖️

Outcome

  • No breach of the Code was ruled.
  • The Panel found the complainant had not established, on the balance of probabilities, that the conversation promoted Tysabri or encouraged the guest to ask for Tysabri.
  • The Panel found no evidence that the conversation was disguised promotion.
  • The Panel ruled that high standards had been maintained and there was no failure to maintain a high standard of ethical conduct.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training